4-[2-(4-cyanophenyl)-7-methyl-4-oxo-1,11a-dihydropyrimido[1,2-b]diazocin-10-yl]benzoic acid | 1221132-41-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并嘧啶类
• 英文名称: 4-[2-(4-cyanophenyl)-7-methyl-4-oxo-1,11a-dihydropyrimido[1,2-b]diazocin-10-yl]benzoic acid
• CAS: 1221132-41-7
• 化学式: C₂₄H₁₈N₄O₃
• 分子量: 410.432
• InChiKey: ZMJIHZSHZXYUMW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  31
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF
  申请人：Xu Lifeng

  公开号：US20120178915A1

  公开（公告）日：2012-07-12

  This invention relates with the arylheterocycle-fused pyrimidines, derivatives and analogs of formula I: or stereoisomers, tautoers, prodrugs, pharmaceutically acceptable salts, complex salts or solvates thereof, wherein: A-cycle is of 3-8 saturated or unsaturated arylheterocycles or aliheterocyclic, containing 1-4 heteroatoms, B-cycle 5-8 member saturated or unsaturated heterocycle containing 1-4 heteroatoms; X 1 , X 2 , X 3 , X 4 are, independently at each occurrence, C, O, S, Se, N and P elements; R 1 , R 2 , R 3 is a substituent containing alicyclic group, arylcycle group, heterocyclic group, adamantane alkyl, adamantane heterocycle, adamantane analogs, sugar group, hydroxyl group, amino acid group or a combination of the above substituents. This invention also relates with their preparative methods and applications.

  该发明涉及与芳基杂环融合的嘧啶类化合物、衍生物和类似物的公式I：或其立体异构体、互变异构体、前药、药学上可接受的盐、复盐或溶剂化合物，其中：A环是由3-8个饱和或不饱和的芳基杂环或芳杂环组成，含有1-4个杂原子，B环是由5-8个成员的饱和或不饱和杂环组成，含有1-4个杂原子；X1、X2、X3、X4在每次出现时独立地是C、O、S、Se、N和P元素；R1、R2、R3是含有脂环基团、芳环基团、杂环基团、金刚烷烷基、金刚烷杂环、金刚烷类似物、糖基、羟基、氨基酸基团或上述基团的组合的取代基。该发明还涉及它们的制备方法和应用。